Clinical Trial Update: The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing ARQ-151 cream in adults with chronic plaque psoriasis completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ARQ-151 cream (ARQ-151)

Snippet

Sponsor: Arcutis Biotherapeutics, Inc. | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2022-08-10